Fundraising FoxDnatrix
Houston, US · Delaware corporation · 3 known investors
Find your way into Dnatrix
Sign up to see every warm intro you have to Dnatrix
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Dnatrix team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Board
DW
Daniel WatkinsBoard director
RM
Reenie McCarthyBoard director
DP
Drew PardollBoard director
FP
Francis Patrick McCormickBoard director
Investors · 3
Texas Ventureslisted by Texas VenturesHoustonvia E. Scott Crist · inferred
How we know: Texas Ventures's portfolio page · Not right? Tell us
Mercury FundreportedHouston · $250K – $4M
How we know: a partner's Signal profile · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$28.3M disclosed across 2 rounds · 2014–2018
▶$15.5MraisedSep 2018 · 40 investors · BiotechnologyRule 506(b)
▶$15.5MraisedSep 2018 · 40 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Drew PardollDirector
- Brian MooneyExecutive Officer
- Daniel WatkinsDirector
- Francis Patrick McCormickDirector
- Frank TufaroExecutive Officer, Director
- Isaac ChengDirector
- Offering amount
- $41.2M
- Amount sold
- $15.5M
- First sale
- Sep 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$12.8MraisedOct 2014 · 31 investors · BiotechnologyRule 506(b)
▶$12.8MraisedOct 2014 · 31 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Frank TufaroExecutive Officer, Director
- Daniel WatkinsExecutive Officer, Director
- Francis Patrick McCormickDirector
- Reenie McCarthyDirector
- Offering amount
- $18.8M
- Amount sold
- $12.8M
- Minimum investment
- $25.5K
- First sale
- Oct 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Dnatrix went on to found or lead other companies.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2022 | $852.6K |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2014 | $160.6K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- Who are Dnatrix's investors?
- Dnatrix's investors include Targeted Technology Funds, Texas Ventures, Mercury Fund.
- How much funding has Dnatrix raised?
- Dnatrix has disclosed $28.3M raised across 2 rounds.
- Where is Dnatrix headquartered?
- Dnatrix is headquartered in Houston, US.